KYMR |
Kymera Therapeutics, Inc. |
Jun 18, 2024 |
1 |
$0 |
4 |
Jun 20, 2024 |
Director |
RAPP |
Rapport Therapeutics, Inc. |
Jun 6, 2024 |
0 |
$0 |
3 |
Jun 6, 2024 |
Director |
BEAM |
Beam Therapeutics Inc. |
Jun 5, 2024 |
1 |
$0 |
4 |
Jun 7, 2024 |
Director |
PROK |
PROKIDNEY CORP. |
Jun 29, 2023 |
1 |
$0 |
4 |
Jul 3, 2023 |
Director |
KYMR |
Kymera Therapeutics, Inc. |
Jun 15, 2023 |
1 |
$0 |
4 |
Jun 20, 2023 |
Director |
BEAM |
Beam Therapeutics Inc. |
Jun 6, 2023 |
1 |
$0 |
4 |
Jun 8, 2023 |
Director |
AGIO |
AGIOS PHARMACEUTICALS, INC. |
Dec 31, 2022 |
1 |
$0 |
5 |
Feb 3, 2023 |
Director |
BEAM |
Beam Therapeutics Inc. |
Sep 1, 2022 |
1 |
$0 |
4 |
Sep 2, 2022 |
Director |
PROK |
PROKIDNEY CORP. |
Jul 11, 2022 |
2 |
$0 |
4 |
Jul 13, 2022 |
Director |
PROK |
PROKIDNEY CORP. |
Jul 11, 2022 |
0 |
$0 |
3 |
Jul 13, 2022 |
Director |
AGIO |
AGIOS PHARMACEUTICALS, INC. |
Jun 21, 2022 |
2 |
$0 |
4 |
Jun 23, 2022 |
Director |
AGIO |
AGIOS PHARMACEUTICALS, INC. |
May 20, 2022 |
2 |
$0 |
4 |
May 24, 2022 |
Director |
KYMR |
Kymera Therapeutics, Inc. |
Jan 18, 2022 |
1 |
$0 |
4 |
Jan 19, 2022 |
Director |
KYMR |
Kymera Therapeutics, Inc. |
Jan 17, 2022 |
0 |
$0 |
3 |
Jan 19, 2022 |
Director |
ALNY |
ALNYLAM PHARMACEUTICALS, INC. |
Dec 21, 2021 |
4 |
-$1.25M |
4 |
Dec 23, 2021 |
Chief Executive Officer, Director |
ALNY |
ALNYLAM PHARMACEUTICALS, INC. |
Dec 10, 2021 |
8 |
$400K |
4 |
Dec 14, 2021 |
Chief Executive Officer, Director |
ALNY |
ALNYLAM PHARMACEUTICALS, INC. |
Nov 12, 2021 |
7 |
-$5.59M |
4 |
Nov 12, 2021 |
Chief Executive Officer, Director |
BEAM |
Beam Therapeutics Inc. |
Nov 5, 2021 |
1 |
$0 |
4 |
Nov 8, 2021 |
Director |
BEAM |
Beam Therapeutics Inc. |
Nov 5, 2021 |
0 |
$0 |
3 |
Nov 8, 2021 |
Director |
ALNY |
ALNYLAM PHARMACEUTICALS, INC. |
Aug 13, 2021 |
7 |
-$6.55M |
4 |
Aug 16, 2021 |
Chief Executive Officer, Director |
AGIO |
AGIOS PHARMACEUTICALS, INC. |
May 28, 2021 |
3 |
$0 |
4 |
Jun 2, 2021 |
Director |
AGIO |
AGIOS PHARMACEUTICALS, INC. |
May 20, 2021 |
2 |
$0 |
4 |
May 24, 2021 |
Director |
ALNY |
ALNYLAM PHARMACEUTICALS, INC. |
May 13, 2021 |
9 |
-$4.2M |
4 |
May 17, 2021 |
Chief Executive Officer, Director |